ANVISA Explains Innovative Online Optimized Assessment Project

DIA: Driving Insights to Action

Mar 14, 202314:44Science & Medicine

For regulators in Brazil, the pandemic’s aftermath includes a backlog of post-approval changes, delayed by emergency development of COVID-19 vaccines and therapies, related to biologic product quality. ANVISA’s new Onlin...

Related Episodes

Continue listening to more episodes from DIA: Driving Insights to Action.

DIA/Tufts CSDD Research: AI Saving Time in Drug Development

Jan 17, 2025 - 11:13

DIA and the Tufts Center for the Study of Drug Development (Tufts CSDD), in collaboration with 16 biophar...

DIA: Your Partner in Life Sciences Training and Development

Nov 6, 2024 - 14:16

This podcast by the Drug Information Association (DIA) highlights the significant benefits of investing i...

DIA: Going Beyond the Traditional Definition of Drug Development

May 29, 2024 - 1:56

In this DIA 60th anniversary interview, former Board President Ling Su shares his thoughts on the two mos...

GPP Experts Explain Authorship Algorithm

Apr 23, 2024 - 7:39

Good Publication Practice (GPP) experts explain the authorship algorithm designed to weigh each author's...

"Dossier in the Cloud" Democratizing Global Access

Apr 2, 2024 - 2:37

Accumulus Synergy CEO Francisco Nogueira shares expectations for the outcomes of a post-approval changes...

DIA: A Place Where You Can Make a Difference

Mar 28, 2024 - 1:40

Listen to former DIA Board President Minnie Baylor-Henry’s special message to DIA members as part of DIA’...

Autumn’s Leukemia Story: Regimens, Recovery, and Realizations

Dec 4, 2023 - 19:58

A few years ago, 8-year-old Autumn noticed a lump on the side of her neck as she was preparing for bed on...

Retiring TGA Head Maps Australia’s Post-Pandemic Future

Jul 17, 2023 - 18:01

In April 2023, Professor John Skerritt retired after 11 years of exemplary public service as deputy secre...